Iclusig
Ended Awarded Last action
- Contract number
- 36C26024F0589
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $27,913
Award facts
- Contract value 100% obligated
- $27,913.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Earth City, MO 63045, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products, is for the delivery of the oncology medication ICLUSIG (ponatinib) to the U.S. Department of Veterans Affairs (VA). The $27,913.44 firm-fixed-price delivery order is placed against Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs and has a completion date of September 19, 2024.
The contract is not set aside and represents an ongoing supply relationship between Takeda and the VA, as evidenced by the company's $13 million Blanket Purchase Agreement (BPA) with the VA National Acquisition Center, which was awarded in October 2019 and is also for the provision of ICLUSIG to multiple VA medical facilities nationwide. This long-term agreement underscores Takeda's status as a key supplier of critical pharmaceuticals to support the healthcare needs of veterans through the federal contracting system.
Quick answers
Who was awarded contract 36C26024F0589?
36C26024F0589 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on August 20, 2024.
How much is contract 36C26024F0589 worth?
The government has obligated $27,913 on 36C26024F0589.
Is contract 36C26024F0589 an order under another contract?
Yes. 36C26024F0589 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0589 competed?
The extent of competition for 36C26024F0589 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award